Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.

PCOS is a long-term condition that needs more research for better understanding and treatment.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

The girl with autoimmune hair loss might regrow hair within a year, and treatments can help but not prevent recurrence; dermatologist referral and corticosteroids are recommended.

QR 678 and QR678 Neo treatments are effective for hair loss in women with PCOS.

More severe hair loss links to thicker heart fat, suggesting possible heart disease risk.

Scalp massages may help stabilize or regrow hair in people suffering from hair loss, regardless of age, gender, or use of other treatments.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

Treat hair loss with medicine, continue indefinitely.

PCOS patients, especially obese ones, often lack vitamin D and may need supplements and lifestyle changes.

Ayurvedic treatment and Yoga Basti therapy improved a woman's PCOS symptoms.

Early intervention and patient education are crucial for managing alopecia areata.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Hair restoration can be achieved through non-surgical treatments like minoxidil, antiandrogens, phototherapy, and PRP procedures, or through surgical methods like hair transplantation. Continued treatment is needed to maintain results, and full results are visible after 12-18 months.

Hair loss in young men in Central India is linked to severe heart disease.

The document concludes that personalized treatment, including lifestyle changes and medication, is essential for managing PCOS in teenagers, while also addressing their psychological well-being.

The gene Foxn1 is important for hair growth, and understanding it may lead to new alopecia treatments.

No treatment alters the natural progression of alopecia areata, and effectiveness varies, with some possibly working better in children.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Using platelet-rich plasma in hair restoration surgery significantly improves hair density after 6 months and is safe to use.

Alopecia patients have less GPER-1, which might affect hair loss.

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

Korean patients with androgenetic alopecia may have a higher risk of heart-related health issues and could benefit from early heart screening and healthier lifestyles.

Severe hair loss (androgenetic alopecia) is linked to higher risk of heart disease (cardiovascular atherosclerosis).

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.